Lumaad, Jenileane D.
HRN: 18-35-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2022
AMPICILLIN 1GM (VIAL)
04/23/2022
04/24/2022
IVT
2g
Now Then Q6
PROM X 8 Hours (thickly Meconium Stained Amniotic Fluid)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes